Correlation Between Bausch Health and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Bausch Health and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and Elevation Oncology, you can compare the effects of market volatilities on Bausch Health and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Elevation Oncology.
Diversification Opportunities for Bausch Health and Elevation Oncology
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bausch and Elevation is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Bausch Health i.e., Bausch Health and Elevation Oncology go up and down completely randomly.
Pair Corralation between Bausch Health and Elevation Oncology
Considering the 90-day investment horizon Bausch Health Companies is expected to generate 0.72 times more return on investment than Elevation Oncology. However, Bausch Health Companies is 1.4 times less risky than Elevation Oncology. It trades about 0.17 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.02 per unit of risk. If you would invest 607.00 in Bausch Health Companies on September 2, 2024 and sell it today you would earn a total of 230.00 from holding Bausch Health Companies or generate 37.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bausch Health Companies vs. Elevation Oncology
Performance |
Timeline |
Bausch Health Companies |
Elevation Oncology |
Bausch Health and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bausch Health and Elevation Oncology
The main advantage of trading using opposite Bausch Health and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.Bausch Health vs. Crinetics Pharmaceuticals | Bausch Health vs. Enanta Pharmaceuticals | Bausch Health vs. Amicus Therapeutics | Bausch Health vs. Connect Biopharma Holdings |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |